Product Information
EVEXITHROID 30 MG TABLET is a generic product labeled by Trifluent Pharma LLC, priced at $0.5962 per EA under NDC 73352069410. Its NADAC has been published 31 times since Jan 21, 2026.
Strength
19; 4.5 ug/1; ug/1
Manufacturer
Trifluent Pharma LLCNDC
73352069410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE; LIOTHYRONINEApproval Type
Unapproved
On Market Since
10/12/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEXITHROID 30 MG TABLET has been published 31 times since Jan 21, 2026, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5962 per EA |
|---|---|
| All-time high | $0.5962 (Aug 19, 2026) |
| All-time low | $0.5842 (Jan 21, 2026) |
| 52-week high | $0.5962 |
| 52-week low | $0.5842 |
| Median price | $0.5887 |
| Average price | $0.5904 |
| Largest weekly change | +1.3% (Jun 17, 2026) |
| Weeks tracked | 31 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOTHYROXINE and LIOTHYRONINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EVEXITHROID 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEXITHROID 30 MG TABLET, manufactured by Trifluent Pharma LLC, is $0.5962 per EA (NDC 73352069410), effective Aug 19, 2026.
How has the price of EVEXITHROID 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEXITHROID 30 MG TABLET has risen 2.1%. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for EVEXITHROID 30 MG TABLET?
Since Jan 21, 2026, the NADAC for EVEXITHROID 30 MG TABLET has ranged from a low of $0.5842 (Jan 21, 2026) to a high of $0.5962 (Aug 19, 2026), with a median of $0.5887 per EA.
Are there cheaper alternatives to EVEXITHROID 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of EVEXITHROID 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EVEXITHROID 30 MG TABLET?
EVEXITHROID 30 MG TABLET (NDC 73352069410) is labeled by Trifluent Pharma LLC, and CMS classifies it as a generic product.